Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2000;36:1002-1007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berthiaume, N.
Right arrow Articles by D’Orléans-Juste, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berthiaume, N.
Right arrow Articles by D’Orléans-Juste, P.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Animal models of human disease
Right arrow Genetically altered mice
Right arrow Hypertension - basic studies
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2000;36:1002.)
© 2000 American Heart Association, Inc.


Scientific Contributions

Heterozygous Knock-Out of ETB Receptors Induces BQ-123–Sensitive Hypertension in the Mouse

Nathalie Berthiaume; Masashi Yanagisawa; Julie Labonté; Pedro D’Orléans-Juste

From the Department of Pharmacology, Institute of Pharmacology Medical School, Université de Sherbrooke, Sherbrooke (Québec), Canada (N.B., J.L., P.D.-J.); and Howard Hughes Medical Institute and Department of Molecular Genetics, UT Southwestern Medical Center, Dallas, Tex (M.Y.).

Correspondence to Pedro D’Orléans-Juste, Department of Pharmacology, Institute of Pharmacology Medical School, Université de Sherbrooke, Sherbrooke (Québec), J1H 5N4, Canada. E-mail labpdj{at}courrier.usherb.ca

Abstract—Homozygous knock-out of ETA or ETB receptor genes results in lethal developmental phenotypes in the mouse. Such deleterious phenotypes do not occur in heterozygous littermates. However, it remains to be determined whether mice partially defective in ETA or ETB receptors display significant alterations in their responses to exogenous or endogenous endothelin-1 (ET-1). Furthermore, the anesthetized ETB (+/-) knock-out mice showed a significantly higher mean arterial blood pressure than the ETA (+/-) knock-out or their wild-type littermates. The pressor response to ET-1 but not to a selective ETB agonist, IRL-1620, was significantly reduced in the ETA (+/-) knock-out mice. In ETB (+/-) knock-out mice, the pressor effect of IRL-1620 was more markedly altered than those induced by ET-1. In wild-type mice, both ETA and ETB receptors were found to be involved in the pressor effect of ET-1, as confirmed by the significant and specific antagonism induced by either BQ-123 (ETA antagonist) or BQ-788 (ETB antagonist). Also, ETA-selective or mixed ETA/ETB- but not ETB-selective antagonists reversed the hypertensive state of the ETB (+/-) knock-out mice to the level of wild-type littermates. Finally, radiolabeled ET-1 plasmatic clearance was altered in ETB (+/-) but not ETA (+/-) knock-out mice when compared with wild-type animals. Thus, heterozygous knock-out of ETB receptors results in a hypertensive state, suggesting an important physiological role for that particular receptorial entity in opposing the endogenous ET-1–dependent pressor effects in the mouse.


Key Words: receptors, genetic • arterial pressure • mice




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. B. Bender and R. E. Klabunde
Altered role of smooth muscle endothelin receptors in coronary endothelin-1 and {alpha}1-adrenoceptor-mediated vasoconstriction in Type 2 diabetes
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2281 - H2288.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. I. Boesen and D. M. Pollock
Effect of chronic IL-6 infusion on acute pressor responses to vasoconstrictors in mice
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1745 - H1749.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Lange, M. Kammerer, M. E. Hegi, S. Grotegut, A. Dittmann, W. Huang, E. Fluri, G. W. Yip, M. Gotte, C. Ruiz, et al.
Endothelin Receptor Type B Counteracts Tenascin-C-Induced Endothelin Receptor Type A-Dependent Focal Adhesion and Actin Stress Fiber Disorganization
Cancer Res., July 1, 2007; 67(13): 6163 - 6173.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M.-Y. Chang, E. Parker, M. El Nahas, J. L. Haylor, and A. C.M. Ong
Endothelin B Receptor Blockade Accelerates Disease Progression in a Murine Model of Autosomal Dominant Polycystic Kidney Disease
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 560 - 569.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Zhou, S. Mitra, S. Varadharaj, N. Parinandi, J. L. Zweier, and N. A. Flavahan
Increased Expression of Cyclooxygenase-2 Mediates Enhanced Contraction to Endothelin ETA Receptor Stimulation in Endothelial Nitric Oxide Synthase Knockout Mice
Circ. Res., June 9, 2006; 98(11): 1439 - 1445.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
X. Guo and T. Yang
Endothelin B receptor antagonism in the rat renal medulla reduces urine flow rate and sodium excretion.
Experimental Biology and Medicine, June 1, 2006; 231(6): 1001 - 1005.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
L. J. Mullins, M. A. Bailey, and J. J. Mullins
Hypertension, Kidney, and Transgenics: A Fresh Perspective
Physiol Rev, April 1, 2006; 86(2): 709 - 746.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. D. Paasche, T. Attramadal, K. Kristiansen, M. P. Oksvold, H. K. Johansen, H. S. Huitfeldt, S. G. Dahl, and H. Attramadal
Subtype-Specific Sorting of the ETA Endothelin Receptor by a Novel Endocytic Recycling Signal for G Protein-Coupled Receptors
Mol. Pharmacol., May 1, 2005; 67(5): 1581 - 1590.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Just, A. J. M. Olson, J. R. Falck, and W. J. Arendshorst
NO and NO-independent mechanisms mediate ETB receptor buffering of ET-1-induced renal vasoconstriction in the rat
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1168 - R1177.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Laflamme, C. J. Roberge, J. Labonte, S. Pouliot, P. D'Orleans-Juste, F. A. Auger, and L. Germain
Tissue-Engineered Human Vascular Media With a Functional Endothelin System
Circulation, February 1, 2005; 111(4): 459 - 464.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Zhou, W. P. Dirksen, J. L. Zweier, and M. Periasamy
Endothelin-1-induced responses in isolated mouse vessels: the expression and function of receptor types
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H573 - H578.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
X. Zhang, A. F. Clark, and T. Yorio
Interactions of Endothelin-1 with Dexamethasone in Primary Cultured Human Trabecular Meshwork Cells
Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5301 - 5308.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. D. Paasche, T. Attramadal, C. Sandberg, H. K. Johansen, and H. Attramadal
Mechanisms of Endothelin Receptor Subtype-specific Targeting to Distinct Intracellular Trafficking Pathways
J. Biol. Chem., August 31, 2001; 276(36): 34041 - 34050.
[Abstract] [Full Text] [PDF]